Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: Characterization, stability assessment and cytotoxicity

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 393-399

  How, Chee Wun ^a   Rasedee, Abdullah ^a   Manickam, Sivakumar ^b   Rosli, Rozita ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

Absorbance; Drug delivery; Lipid nanoparticles; Mammary adenocarcinoma cell line; Nanostructured lipid carrier (NLC); Ostwald ripening; Tamoxifen

Indexed keywords

ABSORBANCES; ADENOCARCINOMA CELLS; LIPID NANOPARTICLES; NANOSTRUCTURED LIPID CARRIER (NLC); TAMOXIFEN;

CELL CULTURE; MAMMALS; NANOPARTICLES; OSTWALD RIPENING; PH; SYSTEM STABILITY; ZETA POTENTIAL;

DRUG DELIVERY;

NANOMATERIAL; PHOSPHOLIPID TRANSFER PROTEIN; TAMOXIFEN;

ARTICLE; BREAST ADENOCARCINOMA; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ABSORBANCE; DRUG DELIVERY; LIPID NANOPARTICLES; MAMMARY ADENOCARCINOMA CELL LINE; NANOSTRUCTURED LIPID CARRIER (NLC); OSTWALD RIPENING; TAMOXIFEN;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; HUMANS; LIPIDS; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; TAMOXIFEN;

EID: 84884181355     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.009     Document Type: Article

References (34)

1. Agrawal Y., Petkar K.C., Sawant K.K. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int. J. Pharm. 2010, 401:93-102.
2. Chinsriwongkul A., Chareanputtakhun P., Ngawhirunpat T., Rojanarata T., Sila-on W., Ruktanonchai U., Opanasopit P. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm. Sci. Tech. 2012, 13:1-9.
3. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278:71-77.
4. Muchow M., Maincent P., Müller R.H. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev. Ind. Pharm. 2008, 34:1394-1405.
5. Yuan H., Miao J., Du Y.Z., You J., Hu F.Q., Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm. 2008, 348:137-145.
6. Alkner S., Bendahl P.O., Fernö M., Nordenskjöld B., Rydén L. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial. Eur. J. Canc. 2009, 45:2496-2502.
7. Kim C.S., Choi S.J., Park C.Y., Li C., Choi J.S. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats. Anticancer Res. 2009, 30:79-85.
8. How C.W., Rasedee A., Abbasalipourkabir R. Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80. Afr. J. Biotechnol. 2011, 10:1684-1689.
9. Tadros T.F. Applied surfactants: principles and applications 2005, Wiley-VCH. Hoboken, New Jersey, USA. 1st edn.
10. Fontana G., Maniscalco L., Schillaci D., Cavallaro G., Giammona G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 2005, 12:385-392.
11. Luo Y.F., Chen D.W., Ren L.X., Zhao X.L., Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 2006, 114:53-59.
12. Varshosaz J., Eskandari S., Kennedy R., Tabbakhian M., Minaiyan M. Factors affecting the production of nanostructured lipid carriers of valproic acid. J. Biomed. Nanotechnol. 2013, 9:202-212.
13. Hu F.Q., Jiang S.P., Du Y.Z., Ye Y.Q., Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 2006, 314:83-89.
14. Abbasalipourkabir R., Salehzadeh A., Rasedee A. Delivering tamoxifen within solid lipid nanoparticles. Pharm. Tech. 2011, 4:74-79.
15. Tiwari R., Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetis and tissue uptake. Pharm. Nanotechnol. 2011, 415:232-243.
16. Mäder M. Solid lipid nanoparticles as drug carriers. Nanoparticulates as drug carriers. Nanoparticulates As Drug Carriers 2006, 187-213. Imperial College Press, London. V.P. Torchilin (Ed.).
17. Pathan I.B., Setty C.M. Enhancement of transdermal delivery of tamoxifen citrate using nanoemulsion vehicle. Int. J. Pharm. Tech. Res. 2011, 3:287-297.
18. Budhian A., Siegel S.J., Winey K.I. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int. J. Pharm. 2007, 336:367-375.
19. Schöpe H.J., Bryant G., van Megen W. Small changes in particle-size distribution dramatically delay and enhance nucleation in hard sphere colloidal suspensions. Phys. Rev. E 2006, 74. Art. No. 060401 (R).
20. Boliren C.F., Huffman D.R. Absorption and Scattering of Light by Small Particles 1983, John Wiley and Sons, New York.
21. Näreoja T., Vehniäinen M., Lamminmäki U., Hänninen P.E., Härmä H. Study on nonspecificity of an immuoassay using Eu-doped polystyrene nanoparticle labels. J. Immunol. Methods 2009, 345:80-89.
22. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14265-14270.
23. Panyam J., Sahoo S.K., Prabha S., Bargar T., Labhasetwar V. Fluorescene and electron microscopy probes for cellular and tissue uptake of poly(-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 2003, 262:1-11.
24. Gaumet M., Vargas A., Gurny R., Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 2008, 69:1-9.
25. Gulari E., Tsunashima Y., Chu B. Photon correlation spectroscopy of particle distributions. J. Chem. Phys. 1979, 70:3965-3972.
26. Jeong S.H., Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int. J. Pharm. 2008, 361:26-32.
27. Dash S., Murthy P.N., Nath L., Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 2010, 67:217-223.
28. Guo H., Shi Y. A novel zein-based dry coating tablet design for zero-order release. Int. J. Pharm. 2009, 370:81-86.
29. Lacatusu I., Badea N., Murariu A., Meghea A. The encapsulation effect of UV molecular absorbers into biocompatible lipid nanoparticles. Nanoscale Res. Lett. 2011, 6:73.
30. Shah K.A., Joshi M.D., Patravale V.B. Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin. J. Biomed. Nanotechnol. 2009, 5:396-400.
31. Serpe L., Catalano M.G., Cavalli R., Ugazio E., Bosco O., Canaparo R., Muntoni E., Frairia R., Gasco M.R., Eandi M., Zara G.P. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur. J. Pharm. Biopharm. 2004, 58:673-680.
32. How C.W., Rasedee A., Abbasalipourkabir R. Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil and polysorbate 80. IEEE Trans. Nanobiosci. 2012, 2:72-78.
33. Joshi M., Pathak S., Sharma S., Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int. J. Pharm. 2008, 364:119-126.
34. Hassan M.A. A long acting ophthalmic gel formulations of atenolol. Drug Dev. Ind. Pharm. 2007, 33:1192-1198.